These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9848356)

  • 1. Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis.
    Haworth CS; Selby PL; Webb AK; Mawer EB; Adams JE; Freemont TJ
    Lancet; 1998 Nov; 352(9142):1753-4. PubMed ID: 9848356
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation.
    Aris RM; Lester GE; Renner JB; Winders A; Denene Blackwood A; Lark RK; Ontjes DA
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):941-6. PubMed ID: 10988110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cytokines and pamidronate-induced bone pain in adults with cystic fibrosis.
    Teramoto S; Matsuse T; Ouchi Y
    Lancet; 1999 Feb; 353(9154):750. PubMed ID: 10073535
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis.
    Haworth CS; Selby PL; Adams JE; Mawer EB; Horrocks AW; Webb AK
    Thorax; 2001 Apr; 56(4):314-6. PubMed ID: 11254825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis.
    Haworth CS; Selby PL; Webb AK; Adams JE; Freemont TJ
    Lancet; 1999 May; 353(9167):1886. PubMed ID: 10359445
    [No Abstract]   [Full Text] [Related]  

  • 6. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
    Cauza E; Etemad M; Winkler F; Hanusch-Enserer U; Partsch G; Noske H; Dunky A
    J Clin Pharm Ther; 2004 Oct; 29(5):431-6. PubMed ID: 15482386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study.
    Allington N; Vivegnis D; Gerard P
    Acta Orthop Belg; 2005 Feb; 71(1):91-7. PubMed ID: 15792214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions.
    Steelman J; Zeitler P
    J Pediatr; 2003 Apr; 142(4):417-23. PubMed ID: 12712060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis.
    Gandrud LM; Cheung JC; Daniels MW; Bachrach LK
    J Pediatr Endocrinol Metab; 2003; 16(6):887-92. PubMed ID: 12948302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent oral disodium pamidronate in established osteoporosis: a 2 year double-masked placebo-controlled study of efficacy and safety.
    Ryan PJ; Blake GM; Davie M; Haddaway M; Gibson T; Fogelman I
    Osteoporos Int; 2000; 11(2):171-6. PubMed ID: 10793877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.
    Noguera A; Ros JB; Pavía C; Alcover E; Valls C; Villaronga M; González E
    J Pediatr Endocrinol Metab; 2003; 16(4):529-36. PubMed ID: 12793604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consultation corner. Bone loss drug gives users a break.
    Bellantoni M
    Johns Hopkins Med Lett Health After 50; 2007 Dec; 19(10):6. PubMed ID: 18225340
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders.
    Wagner S; Poirot I; Vuillerot C; Berard C
    Ann Phys Rehabil Med; 2011 Sep; 54(6):348-58. PubMed ID: 21840280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial.
    Lodder MC; Van Pelt PA; Lems WF; Kostense PJ; Koks CH; Dijkmans BA
    J Rheumatol; 2003 Sep; 30(9):2080-1. PubMed ID: 12966622
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records.
    Pappagallo M; Breuer B; Schneider A; Sperber K
    J Pain Symptom Manage; 2003 Jul; 26(1):678-83. PubMed ID: 12850650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
    Chapman I; Greville H; Ebeling PR; King SJ; Kotsimbos T; Nugent P; Player R; Topliss DJ; Warner J; Wilson JW
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):838-46. PubMed ID: 18823395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.